OIL ASX · Health Care

Optiscan Imaging Ltd

Announcements, last 12 months: 39
Price sensitive, last 12 months: 19
Followed on InvestorPA: Some (Among the 20% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
5 Oct 2026, 9:13 AM	Optiscan Lodges U.S. FDA 510(k) Submission for InVue Price sensitive	AI summary
1 Oct 2026, 2:42 PM	Optiscan Lodges U.S. FDA 510(k) Submission for InForm Price sensitive	AI summary
16 Sep 2026, 9:04 AM	Change of Director's Interest Notice
16 Sep 2026, 8:26 AM	Notification of cessation of securities - OIL
16 Sep 2026, 8:25 AM	Application for quotation of securities - OIL
10 Sep 2026, 8:48 AM	Significant Milestone Reached in ACL Digital Pathology Study Price sensitive	AI summary
10 Sep 2026, 8:43 AM	Change of Director's Interest Notice
10 Sep 2026, 8:40 AM	Application for quotation of securities - OIL
9 Sep 2026, 8:26 AM	Application for quotation of securities - OIL
9 Sep 2026, 8:24 AM	Change of Director's Interest Notice

Guidance history

31 Jan 2025

Optiscan received $0.398m in grant funding during the quarter as part of its $3m Cooperative Research Centres Projects (CRC-P) project for the development of an Edge-AI-enabled gastrointestinal flexible endomicroscope. The company also secured an Advance Overseas Finding through AusIndustry, allowing it to claim R&D tax incentives on eligible overseas costs, providing rebates exceeding $0.5m annually with respect to FY24 and beyond.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow OIL to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.